JBIO Jade Biosciences, Inc. - Common Stock
$23,20
Prezzo · Ago 19, 2026
Fondamentali al Ago 10, 2026
Intervallo 52 sett.
$7–$28
77% of range
Rating Analisti
STRONG BUY
17 analysts
Prezzo Obiettivo
$50
+116% upside
P/E (TTM)
-7.3
ROE
-47.7%
Margine di Profitto Netto
—
JBIO Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane
Prezzo
$23.20
Capitalizzazione di Mercato
$1.14B
P/E (TTM)
-7.3
EPS (TTM)
$-3.19
Ricavi (TTM)
—
Rendimento div.
—
ROE
-47.7%
D/E Debito/Patrimonio
—
Intervallo 52 sett.
$7 – $28
JBIO Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione
Configure
Performance decennale Andamento di ricavi, utile netto, margini e EPS
Ricavi e Utile Netto
—
EPS
$-3.19
2021-12-31
→
2025-12-31
Flusso di cassa libero
$-95M
2021-12-31
→
2025-12-31
Margini
—
Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?
Metrica
Tendenza 5 anni
JBIO
Mediana dei peer
P/E (TTM)
-7.3
—
P/B
3.4
2.7
Price / FCF (Prezzo / FCF)
-12.1
—
Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC
Metrica
Tendenza 5 anni
JBIO
Mediana dei peer
ROA
-60.3%
-43.1%
ROE
-47.7%
-49.0%
ROIC
-34.2%
—
Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio
Metrica
Tendenza 5 anni
JBIO
Mediana dei peer
Current Ratio (Rapporto corrente)
21.1
9.0
Quick Ratio
20.3
—
Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y
Metrica
Tendenza 5 anni
JBIO
Mediana dei peer
Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti
Metrica
Tendenza 5 anni
JBIO
Mediana dei peer
Dividendi Rendimento, payout ratio, storico dividendi, CAGR 5Y
Dividend Yield
—
Rapporto di Distribuzione Utili
—
CAGR Dividendi 5Y
—
| Data ex-dividendo | Importo |
|---|---|
| 29 Aprile 2025 | $2,4000 |
JBIO Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo
COMPRA
17 analisti
- Acquisto forte 8 47,1%
- Compra 8 47,1%
- Mantieni 1 5,9%
- Vendi 0 0,0%
- Vendita forte 0 0,0%
Target Price a 12 Mesi
8 analisti · 2026-08-14
Mediana
$47.00
Media
$50.12
← Sotto tutti i target
$23.20
Basso
$40.00
Alto
$77.00
Target mediano
$47.00
+102,6%
Target medio
$50.12
+116,1%
Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili
Sorpresa media
1.0%
| Periodo | EPS Actual | EPS Stimato | Sorpresa |
|---|---|---|---|
| 31 Marzo 2026 | $-0.57 | $-0.49 | -0.08% |
| 31 Dicembre 2025 | $-0.59 | $-0.48 | -0.11% |
| 30 Settembre 2025 | $-0.48 | $-0.69 | 0.21% |
| 30 Giugno 2025 | $-0.86 | $-0.44 | -0.42% |
| 31 Marzo 2025 | $-3.15 | $-8.57 | 5.4% |
Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore
| Ticker | Capitalizzazione di Mercato | P/E | Rev YoY | Margine Netto | ROE | Margine lordo |
|---|---|---|---|---|---|---|
| JBIO | $761M | -4.8 | — | — | -47.7% | — |
| FBRX | $353M | -5.8 | 106.6% | -2555.2% | -86.9% | — |
| ZYME | $1.97B | -24.4 | 38.9% | -76.6% | -26.9% | — |
| BCAX | $953M | -6.7 | — | — | -33.0% | — |
| TYRA | $1.41B | -13.1 | — | — | -42.7% | — |
| XNCR | $1.10B | -12.3 | 13.7% | -73.2% | -14.0% | — |
| TRAX | — | — | — | — | — | — |
| VIR | $841M | -1.9 | -7.6% | -638.9% | -51.1% | — |
| ABSI | $529M | -4.2 | -38.2% | -4113.7% | -63.5% | — |
| AVBP | $854M | -4.7 | — | — | -59.7% | — |
| PURR | — | — | — | — | — | — |
Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario
Conto Economico 14
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| R&D Expense | $93M | $53M | $64M | $39M | $15M | $8M | |
| SG&A Expense | $20M | $21M | $17M | $15M | $8M | $949.0K | |
| Operating Expenses | $114M | $75M | $81M | $53M | $23M | $9M | |
| Operating Income | $-114M | $-75M | $-81M | $-53M | $-23M | $-9M | |
| Interest Expense | · | · | · | · | · | $75.0K | |
| Other Non-op | $-8.0K | $-19.0K | $-1.0K | $2M | $62.0K | $-722.0K | |
| Pretax Income | $-127M | $-70M | $-75M | $-51M | $-23M | $-10M | |
| Income Tax | $58.0K | $55.0K | $56.0K | $25.0K | $3.0K | · | |
| Net Income | $-127M | $-70M | $-76M | $-52M | $-23M | $-10M | |
| EPS (Basic) | $-3.19 | $-2.44 | $-2.87 | $-2.10 | $-1.87 | · | |
| EPS (Diluted) | $-3.19 | $-2.44 | $-2.87 | $-2.10 | $-1.87 | · | |
| Shares (Basic) | 31,359,958 | 28,582,194 | 26,331,630 | 24,472,104 | 12,293,629 | · | |
| Shares (Diluted) | 31,359,958 | 28,582,194 | 26,331,630 | 24,472,104 | 12,293,629 | · | |
| EBITDA | $-114M | $-75M | $-81M | $-53M | $-23M | · |
Stato Patrimoniale 21
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $88M | $69M | $23M | $22M | $54M | $5M | |
| Short-term Investments | $248M | $0 | $99M | $107M | $113M | · | |
| Prepaid Expense | $13M | $268.0K | $2M | $2M | $7M | $103.0K | |
| Current Assets | $349M | $70M | $124M | $131M | $174M | $5M | |
| PP&E (Net) | $170.0K | · | $288.0K | $242.0K | $186.0K | $39.0K | |
| PP&E (Gross) | · | · | · | · | · | $40.0K | |
| Accum. Depreciation | · | · | · | · | · | $1.0K | |
| Other Non-current Assets | $69.0K | $3M | $2M | $3M | $302.0K | · | |
| Total Assets | $350M | $73M | $127M | $135M | $175M | $5M | |
| Accounts Payable | $2M | $1M | $2M | $3M | $1M | $618.0K | |
| Accrued Liabilities | $9M | $4M | · | · | · | · | |
| Current Liabilities | $17M | $12M | $18M | $8M | $3M | $2M | |
| Capital Leases | $724.0K | $0 | $255.0K | $705.0K | $382.0K | · | |
| Total Liabilities | $17M | $120M | $18M | $9M | $3M | $2M | |
| Common Stock | $5.0K | $1.0K | $3.0K | $2.0K | $2.0K | · | |
| Paid-in Capital | $507M | $179.0K | $273M | $215M | $209M | $63.0K | |
| Retained Earnings | $-174M | $-47M | $-163M | $-88M | $-36M | $-13M | |
| AOCI | $129.0K | $0 | $237.0K | $-466.0K | $-59.0K | · | |
| Stockholders' Equity | $333M | $-47M | $109M | $127M | $172M | $-13M | |
| Liabilities + Equity | $350M | $73M | $127M | $135M | $175M | $5M | |
| Shares Outstanding | 49,316,287 | 3,672,794 | 27,762,703 | 24,722,974 | 24,410,393 | 243,076 |
Flusso di cassa 10
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Stock-based Comp | $20M | $11M | $12M | $5M | $2M | $58.0K | |
| Deferred Tax | $-44.0K | · | · | · | · | · | |
| Operating Cash Flow | $-95M | $-71M | $-57M | $-39M | $-27M | $-8M | |
| CapEx | $196.0K | · | $142.0K | $195.0K | $181.0K | · | |
| Investing Cash Flow | $-247M | $56M | $12M | $7M | $-113M | · | |
| Stock Issued | · | $24M | $45M | · | $127M | · | |
| Net Stock Activity | · | $24M | $45M | · | $127M | · | |
| Financing Cash Flow | $361M | $25M | $46M | $396.0K | $190M | $9M | |
| Net Change in Cash | $19M | $10M | $1M | $-32M | $50M | $1M | |
| Free Cash Flow | $-95M | · | $-57M | $-39M | $-28M | · |
Redditività 3
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| ROA | -60.3% | -67.0% | -57.5% | -33.2% | -25.5% | · | |
| ROE | -47.7% | -233.8% | -64.2% | -38.8% | -13.0% | · | |
| ROIC | -34.2% | -97.7% | -74.4% | -42.0% | -13.4% | · |
Liquidità e Solvibilità 2
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 21.1 | 20.9 | 7.0 | 16.9 | 68.4 | · | |
| Quick Ratio | 20.3 | 20.5 | 6.9 | 16.6 | 65.6 | · |
Valutazione (TTM) 8
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Net Income TTM | $-127M | $-70M | $-76M | $-52M | $-23M | · | |
| Market Cap | $761M | $2.69B | $21.99B | $25.35B | $10.07B | · | |
| P/E | -4.8 | -38.0 | -276.0 | -488.3 | -220.7 | · | |
| P/B | 2.3 | 35.2 | 200.9 | 200.0 | 58.4 | · | |
| P / Tangible Book | 2.3 | · | 200.9 | 200.0 | 58.4 | · | |
| P / Cash Flow | -8.0 | -37.8 | -387.3 | -648.1 | -367.6 | · | |
| P / FCF | -8.0 | · | -386.3 | -644.8 | -365.2 | · | |
| Earnings Yield | -20.7% | -2.6% | -0.36% | -0.20% | -0.45% | · |
Conto Economico 13
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $50M | $36M | $29M | $22M | $23M | $20M | $-2M | $14M | $21M | $20M | $18M | $17M | $16M | $13M | $12M | $11M | |
| SG&A Expense | $9M | $7M | $6M | $5M | $5M | $3M | $11M | $1M | $5M | $5M | $4M | $4M | $4M | $4M | $4M | $3M | |
| Operating Expenses | $59M | $43M | $55M | $27M | $28M | $23M | $9M | $15M | $26M | $25M | $22M | $21M | $20M | $18M | $16M | $14M | |
| Operating Income | $-59M | $-43M | $-55M | $-27M | $-28M | $-23M | $-9M | $-15M | $-26M | $-25M | $-22M | $-21M | $-20M | $-18M | $-16M | $-14M | |
| Other Non-op | $-62.0K | $-9.0K | $4M | $-28.0K | $0 | $0 | $-1M | $0 | $1M | $-3.0K | $-2M | $1.0K | $1M | $1M | $2M | $4.0K | |
| Pretax Income | $-56M | $-40M | · | · | $-32M | $-38M | · | · | · | · | · | · | · | · | · | · | |
| Income Tax | $15.0K | $16.0K | $58.0K | $0 | $0 | · | · | $0 | · | · | · | · | · | · | · | · | |
| Net Income | $-56M | $-40M | $-32M | $-25M | $-32M | $-38M | $-5M | $-16M | $-25M | $-23M | $-20M | $-20M | $-19M | $-17M | $-15M | $-14M | |
| EPS (Basic) | $-0.76 | $-0.57 | $-1.76 | $-0.48 | $-0.86 | $-12.10 | $4.41 | $-5.16 | $-0.86 | $-0.83 | $-0.73 | $-0.71 | $-0.76 | $-0.67 | $-0.60 | $-0.56 | |
| EPS (Diluted) | $-0.76 | $-0.57 | $-1.76 | $-0.48 | $-0.86 | $-12.10 | $4.41 | $-5.16 | $-0.86 | $-0.83 | $-0.73 | $-0.71 | $-0.76 | $-0.67 | $-0.60 | $-0.56 | |
| Shares (Basic) | 61,050,775 | 57,777,165 | -65,640,708 | 39,584,489 | 28,431,158 | 3,155,500 | -31,125,176 | 3,155,500 | 28,756,043 | 27,795,827 | -51,253,264 | 27,640,542 | 25,166,505 | 24,777,847 | -48,803,578 | 24,454,786 | |
| Shares (Diluted) | 61,050,775 | 57,777,165 | -65,640,708 | 39,584,489 | 28,431,158 | 3,155,500 | -31,125,176 | 3,155,500 | 28,756,043 | 27,795,827 | -51,253,264 | 27,640,542 | 25,166,505 | 24,777,847 | -48,803,578 | 24,454,786 | |
| EBITDA | $-59M | $-43M | · | $-27M | $-28M | $-3M | · | $-17M | $-26M | $-25M | · | $-21M | $-20M | $-18M | · | $-14M |
Stato Patrimoniale 19
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $107M | $55M | $88M | $50M | $221M | $44M | $34M | $31M | $31M | $9M | $23M | $32M | $61M | $27M | $22M | $22M | |
| Short-term Investments | $354M | $256M | $248M | $149M | · | $32M | $45M | $58M | $73M | $90M | $99M | $103M | $89M | $92M | $107M | $120M | |
| Prepaid Expense | $10M | $7M | $13M | $2M | $2M | $1M | $1M | $2M | $7M | $4M | $2M | $2M | $2M | $2M | $2M | $3M | |
| Current Assets | $471M | $319M | $349M | $201M | $223M | $77M | $80M | $91M | $111M | $103M | $124M | $138M | $152M | $121M | $131M | $145M | |
| PP&E (Net) | $144.0K | $157.0K | $170.0K | $176.0K | $147.0K | $2.0K | $6.0K | $14.0K | $232.0K | $260.0K | $288.0K | $316.0K | $245.0K | $267.0K | $242.0K | $330.0K | |
| Other Non-current Assets | $69.0K | $69.0K | $69.0K | $174.0K | $60.0K | · | · | $81.0K | $81.0K | $3M | $2M | $2M | $2M | $3M | $3M | $1M | |
| Total Assets | $472M | $319M | $350M | $202M | $224M | $78M | $80M | $91M | $112M | $107M | $127M | $141M | $156M | $124M | $135M | $148M | |
| Accounts Payable | $7M | $4M | $2M | $1M | $8M | $69.0K | $224.0K | $908.0K | $4M | $3M | $2M | $4M | $6M | $5M | $3M | $5M | |
| Accrued Liabilities | $15M | $15M | $9M | $14M | $8M | · | · | · | · | · | · | · | · | · | · | · | |
| Current Liabilities | $32M | $22M | $17M | $22M | $22M | $2M | $4M | $10M | $17M | $16M | $18M | $15M | $13M | $11M | $8M | $8M | |
| Capital Leases | $628.0K | $679.0K | $724.0K | $747.0K | $792.0K | · | · | $81.0K | $206.0K | $329.0K | $255.0K | $358.0K | $476.0K | $591.0K | $705.0K | $800.0K | |
| Total Liabilities | $32M | $23M | $17M | $23M | $22M | $2M | $4M | $10M | $17M | $16M | $18M | $15M | $14M | $11M | $9M | $9M | |
| Common Stock | $6.0K | $5.0K | $5.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $2.0K | $2.0K | $2.0K | |
| Paid-in Capital | $711M | $512M | $507M | $322M | $319M | $311M | $309M | $308M | $306M | $278M | $273M | $269M | $266M | $218M | $215M | $213M | |
| Retained Earnings | $-271M | $-215M | $-174M | $-142M | $-117M | $-236M | $-233M | $-228M | $-211M | $-187M | $-163M | $-143M | $-123M | $-104M | $-88M | $-73M | |
| AOCI | $-660.0K | $-342.0K | $129.0K | $29.0K | $-24.0K | $50.0K | $105.0K | $224.0K | $-83.0K | $-33.0K | $237.0K | $-195.0K | $-223.0K | $-201.0K | $-466.0K | $-771.0K | |
| Stockholders' Equity | $440M | $296M | $333M | $179M | $202M | $75M | $76M | $80M | $94M | $91M | $109M | $126M | $142M | $113M | $127M | $139M | |
| Liabilities + Equity | $472M | $319M | $350M | $202M | $224M | $78M | $80M | $91M | $112M | $107M | $127M | $141M | $156M | $124M | $135M | $148M | |
| Shares Outstanding | 63,556,065 | 49,345,967 | 49,316,287 | 32,626,730 | 32,626,730 | 28,985,019 | 28,985,019 | 28,867,711 | 28,854,750 | 27,898,761 | 27,762,703 | 27,653,187 | 27,601,098 | 24,816,940 | 24,722,974 | 24,506,390 |
Flusso di cassa 8
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $14M | $7M | $11M | $4M | $4M | $2M | $3M | $27.0K | $4M | $4M | $3M | $3M | $3M | $2M | $2M | $1M | |
| Operating Cash Flow | $-44M | $-24M | $-34M | $-22M | $-37M | $-19M | $-11M | $-7M | $-20M | $-24M | $-15M | $-16M | $-15M | $-11M | $-15M | $-10M | |
| CapEx | · | · | $3.0K | $57.0K | · | · | · | · | · | · | $64.0K | $32.0K | $30.0K | $16.0K | $4.0K | $33.0K | |
| Investing Cash Flow | $-98M | $-8M | $-98M | $-149M | $-13M | $13M | $13M | $0 | $18M | $9M | $6M | $-13M | $4M | $15M | $14M | $5M | |
| Stock Issued | · | · | · | · | · | · | $307.0K | $0 | · | · | $0 | $0 | · | · | · | · | |
| Financing Cash Flow | $194M | $-795.0K | $170M | $0 | $191M | $-700.0K | $554.0K | $95M | $24M | $471.0K | $463.0K | $20.0K | $45M | $223.0K | $357.0K | $37.0K | |
| Net Change in Cash | $52M | $-33M | $38M | $-171M | $141M | $-19M | $3M | $88M | $22M | $-14M | $-9M | $-29M | $34M | $4M | $-22.0K | $-5M | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | · | · | · | · | $-11M | · | · |
Redditività 3
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -16.0% | -20.3% | · | -17.2% | -19.1% | -2.7% | · | -14.0% | -18.5% | -20.1% | · | -13.6% | -12.2% | -11.3% | · | -8.2% | |
| ROE | -17.4% | -21.7% | · | -19.4% | -21.7% | -3.0% | · | -15.8% | -21.0% | -22.7% | · | -14.8% | -13.0% | -12.0% | · | -8.5% | |
| ROIC | -13.4% | -14.7% | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
Liquidità e Solvibilità 2
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 14.9 | 14.3 | · | 9.0 | 10.3 | 32.0 | · | 8.8 | 6.5 | 6.7 | · | 9.3 | 11.5 | 11.3 | · | 18.8 | |
| Quick Ratio | 14.6 | 14.0 | · | 8.9 | 10.2 | 31.5 | · | 8.6 | 6.1 | 6.4 | · | 9.2 | 11.3 | 11.2 | · | 18.5 |
Valutazione (TTM) 8
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-153M | $-136M | · | $-112M | $-111M | $-102M | · | $-84M | $-87M | $-78M | · | $-69M | $-61M | $-53M | · | $-43M | |
| Market Cap | $1.41B | $693M | · | $282M | $326M | $2.55B | · | $2.11B | $1.68B | $28.87B | · | $13.13B | $16.57B | $17.52B | · | $14.22B | |
| P/E | -8.3 | -1.0 | · | -1.3 | -1.4 | -12.7 | · | -9.7 | -18.4 | -348.5 | · | -175.9 | -242.0 | -325.3 | · | -329.7 | |
| P/B | 3.2 | 2.3 | · | 1.6 | 1.6 | 33.9 | · | 26.2 | 17.8 | 317.6 | · | 104.5 | 116.7 | 154.9 | · | 102.2 | |
| P / Tangible Book | 3.2 | 2.3 | · | 1.6 | 1.6 | 33.9 | · | 26.2 | 17.8 | 317.6 | · | 104.5 | 116.7 | 154.9 | · | 102.2 | |
| P / Cash Flow | · | -28.8 | · | · | · | -1069.4 | · | · | · | -1219.7 | · | · | · | -1533.6 | · | · | |
| P / FCF | · | · | · | · | · | · | · | · | · | · | · | · | · | -1531.4 | · | · | |
| Earnings Yield | -12.0% | -99.7% | · | -76.4% | -69.8% | -7.9% | · | -10.3% | -5.4% | -0.29% | · | -0.57% | -0.41% | -0.31% | · | -0.30% |
Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni
Conto Economico
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Utile netto | $-127M | $-70M | $-76M | $-52M | $-23M |
| EPS Diluito | $-3.19 | $-2.44 | $-2.87 | $-2.10 | $-1.87 |
Stato Patrimoniale
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Rapporto corrente | 21.1 | 20.9 | 7.0 | 16.9 | 68.4 |
| Quick Ratio | 20.3 | 20.5 | 6.9 | 16.6 | 65.6 |
Flusso di cassa
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flusso di cassa libero | $-95M | — | $-57M | $-39M | $-28M |
Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi
📊
Scegli le metriche che contano per te — fai clic sul ➕ accanto a qualsiasi riga nei Fondamentali Completi sopra.
La tua selezione è salvata e ti segue su tutti i ticker.
Proprietari istituzionali (13F) 161 filer · $1.3B totale · Aggiornato al 30 Giugno 2026
Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.
Attività istituzionale — Q2 2026 vs trimestre precedente
| Nuove posizioni | Posizioni chiuse | Aumentato | Diminuito | Variazione netta delle azioni |
|---|---|---|---|---|
| 58 (+29 vs trimestre precedente) | 15 (+4 vs trimestre precedente) | 52 (+16 vs trimestre precedente) | 26 (-3 vs trimestre precedente) | +12.9M |
Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.
| Istituzione | Valore | Azioni | % di 13F tracciati | Tipo |
|---|---|---|---|---|
| FMR LLC | $160.922.573 | 7.242.240 | 12,56% | Azioni |
| Fairmount Funds Management LLC | $101.178.637 | 4.553.494 | 7,90% | Azioni |
| RA CAPITAL MANAGEMENT, L.P. | $81.571.464 | 3.671.083 | 6,37% | Azioni |
| Venrock Adviser, LLC | $71.556.488 | 3.220.364 | 5,59% | Azioni |
| Bellevue Group AG | $67.948.671 | 3.057.996 | 5,31% | Azioni |
| Paradigm Biocapital Advisors LP | $63.491.539 | 2.857.405 | 4,96% | Azioni |
| STATE STREET CORP | $51.890.033 | 2.335.285 | 4,05% | Azioni |
| VANGUARD CAPITAL MANAGEMENT LLC | $49.878.856 | 2.244.773 | 3,89% | Azioni |
| JANUS HENDERSON GROUP PLC | $43.557.008 | 3.105.669 | 3,40% | Azioni |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $42.458.243 | 1.910.812 | 3,31% | Azioni |
| Polar Capital Holdings Plc | $41.039.940 | 1.846.982 | 3,20% | Azioni |
| Avidity Partners Management LP | $37.789.732 | 1.700.708 | 2,95% | Azioni |
| Remedium Capital Partners, LLC | $35.057.605 | 1.577.750 | 2,74% | Azioni |
| Soleus Capital Management, L.P. | $34.456.332 | 1.550.690 | 2,69% | Azioni |
| BAKER BROS. ADVISORS LP | $27.340.066 | 1.230.426 | 2,13% | Azioni |
| Logos Global Management LP | $24.997.500 | 1.125.000 | 1,95% | Azioni |
| Versant Venture Management, LLC | $22.037.418 | 991.783 | 1,72% | Azioni |
| ACORN CAPITAL ADVISORS, LLC | $21.925.807 | 986.760 | 1,71% | Azioni |
| Foresite Capital Management VI LLC | $19.701.741 | 886.667 | 1,54% | Azioni |
| Balyasny Asset Management L.P. | $19.525.292 | 878.726 | 1,52% | Azioni |
| GEODE CAPITAL MANAGEMENT, LLC | $18.744.951 | 843.337 | 1,46% | Azioni |
| Affinity Asset Advisors, LLC | $18.672.577 | 840.350 | 1,46% | Azioni |
| SAMSARA BIOCAPITAL, LLC | $16.359.186 | 736.237 | 1,28% | Azioni |
| Pictet Asset Management Holding SA | $16.304.325 | 733.768 | 1,27% | Azioni |
| Aberdeen Group plc | $13.801.020 | 621.108 | 1,08% | Azioni |
| GOLDMAN SACHS GROUP INC | $13.387.928 | 602.517 | 1,05% | Azioni |
| MARSHALL WACE, LLP | $12.342.966 | 555.489 | 0,96% | Azioni |
| CITADEL ADVISORS LLC | $12.093.546 | 544.264 | 0,94% | Azioni |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $10.255.152 | 461.528 | 0,80% | Azioni |
| BANK OF AMERICA CORP /DE/ | $10.088.569 | 454.031 | 0,79% | Azioni |
| Blackstone Inc. | $9.672.810 | 435.320 | 0,76% | Azioni |
| Ikarian Capital, LLC | $9.495.694 | 427.349 | 0,74% | Azioni |
| Walleye Capital LLC | $8.116.344 | 365.272 | 0,63% | Azioni |
| MILLENNIUM MANAGEMENT LLC | $6.989.257 | 314.548 | 0,55% | Azioni |
| VANGUARD FIDUCIARY TRUST CO | $6.774.145 | 304.867 | 0,53% | Azioni |
| Connor, Clark & Lunn Investment Management Ltd. | $4.825.229 | 217.157 | 0,38% | Azioni |
| BNP PARIBAS FINANCIAL MARKETS | $4.431.312 | 199.429 | 0,35% | Azioni |
| Point72 Asset Management, L.P. | $3.715.273 | 167.204 | 0,29% | Azioni |
| Opaleye Management Inc. | $3.221.900 | 145.000 | 0,25% | Azioni |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $3.114.989 | 140.886 | 0,24% | Azioni |
| Quantinno Capital Management LP | $2.548.990 | 114.716 | 0,20% | Azioni |
| BOOTHBAY FUND MANAGEMENT, LLC | $2.504.261 | 112.703 | 0,20% | Azioni |
| VANGUARD GROUP INC | $2.491.621 | 161.479 | 0,19% | Azioni |
| Sofinnova Investments, Inc. | $2.386.228 | 107.391 | 0,19% | Azioni |
| AMERIPRISE FINANCIAL INC | $2.378.718 | 107.053 | 0,19% | Azioni |
| Woodline Partners LP | $2.227.977 | 100.269 | 0,17% | Azioni |
| SEVEN GRAND MANAGERS, LLC | $2.222.000 | 100.000 | 0,17% | Azioni |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $2.221.489 | 99.977 | 0,17% | Azioni |
| Atle Fund Management AB | $1.967.714 | 88.556 | 0,15% | Azioni |
| Swiss National Bank | $1.850.926 | 83.300 | 0,14% | Azioni |
| RAYMOND JAMES FINANCIAL INC | $1.749.225 | 78.723 | 0,14% | Azioni |
| Longaeva Partners L.P. | $1.744.292 | 78.501 | 0,14% | Azioni |
| RENAISSANCE TECHNOLOGIES LLC | $1.635.192 | 73.591 | 0,13% | Azioni |
| AMERICAN CENTURY COMPANIES INC | $1.532.736 | 68.980 | 0,12% | Azioni |
| Trexquant Investment LP | $1.517.982 | 68.316 | 0,12% | Azioni |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1.517.626 | 68.300 | 0,12% | Opzione Put |
| Harvest Investment Services, LLC | $1.399.482 | 62.983 | 0,11% | Azioni |
| Corient Private Wealth LP | $1.365.199 | 61.440 | 0,11% | Azioni |
| XTX Topco Ltd | $1.313.046 | 59.093 | 0,10% | Azioni |
| Verdad Advisers, LP | $1.252.852 | 56.384 | 0,10% | Azioni |
| Squarepoint Ops LLC | $1.210.012 | 54.456 | 0,09% | Azioni |
| CITIGROUP INC | $1.166.506 | 52.498 | 0,09% | Azioni |
| Maven Securities LTD | $1.111.000 | 50.000 | 0,09% | Azioni |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | $1.074.870 | 48.374 | 0,08% | Azioni |
| TWO SIGMA INVESTMENTS, LP | $1.007.921 | 45.361 | 0,08% | Azioni |
| Rafferty Asset Management, LLC | $947.216 | 42.629 | 0,07% | Azioni |
| RHUMBLINE ADVISERS | $908.965 | 40.908 | 0,07% | Azioni |
| Russell Investments Group, Ltd. | $869.734 | 39.141 | 0,07% | Azioni |
| VANGUARD ASSET MANAGEMENT, Ltd | $812.963 | 36.587 | 0,06% | Azioni |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $797.698 | 35.900 | 0,06% | Opzione Call |
| Vanguard Global Advisers, LLC | $757.546 | 34.093 | 0,06% | Azioni |
| STATE OF WISCONSIN INVESTMENT BOARD | $702.441 | 31.613 | 0,05% | Azioni |
| BlackRock, Inc. | $673.999 | 30.333 | 0,05% | Azioni |
| ALLIANCEBERNSTEIN L.P. | $664.987 | 47.330 | 0,05% | Azioni |
| WELLINGTON MANAGEMENT GROUP LLP | $635.003 | 28.578 | 0,05% | Azioni |
| Voleon Capital Management LP | $617.205 | 27.777 | 0,05% | Azioni |
| Man Group plc | $580.453 | 26.123 | 0,05% | Azioni |
| D. E. Shaw & Co., Inc. | $526.614 | 23.700 | 0,04% | Azioni |
| Engineers Gate Manager LP | $502.594 | 22.619 | 0,04% | Azioni |
| Aquatic Capital Management LLC | $498.417 | 22.431 | 0,04% | Azioni |
| BARCLAYS PLC | $485.285 | 21.840 | 0,04% | Azioni |
| PROFUND ADVISORS LLC | $475.775 | 21.412 | 0,04% | Azioni |
| Virtus Investment Advisers, LLC | $473.930 | 21.329 | 0,04% | Azioni |
| Bank of New York Mellon Corp | $454.221 | 20.442 | 0,04% | Azioni |
| Ghisallo Capital Management LLC | $444.400 | 20.000 | 0,03% | Azioni |
| MetLife Investment Management, LLC | $438.601 | 19.739 | 0,03% | Azioni |
| KLP KAPITALFORVALTNING AS | $306.636 | 13.800 | 0,02% | Azioni |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $292.037 | 13.143 | 0,02% | Azioni |
| Invesco Ltd. | $284.327 | 12.796 | 0,02% | Azioni |
| NEW YORK STATE COMMON RETIREMENT FUND | $256.019 | 11.522 | 0,02% | Azioni |
| State of New Jersey Common Pension Fund D | $221.445 | 9.966 | 0,02% | Azioni |
| Brevan Howard Capital Management LP | $215.623 | 9.704 | 0,02% | Azioni |
| DELTEC ASSET MANAGEMENT LLC | $209.668 | 9.436 | 0,02% | Azioni |
| Police & Firemen's Retirement System of New Jersey | $204.824 | 9.218 | 0,02% | Azioni |
| UBS Group AG | $194.936 | 8.773 | 0,02% | Azioni |
| Vanguard Investments Australia, Ltd. | $173.916 | 7.827 | 0,01% | Azioni |
| Nuveen, LLC | $136.742 | 6.154 | 0,01% | Azioni |
| NORTHERN TRUST CORP | $113.633 | 5.114 | 0,01% | Azioni |
| MERCER GLOBAL ADVISORS INC /ADV | $109.545 | 4.930 | 0,01% | Azioni |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $109.489 | 4.952 | 0,01% | Azioni |
Insider aziendali 20 insider · 4 dirigenti · 9 direttori
| Insider | Ruolo | Ultima attività | Azioni possedute | Acquisti 12m | Vendite 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Tom Frohlich | Chief Executive Officer | 12 Febbraio 2026 A | 86.331 | 0 | 0 | $0 |
| Bradford D. Dahms | Chief Financial Officer | 12 Febbraio 2026 A | 37.813 | 0 | 0 | $0 |
| Elizabeth Balta | Chief Legal Officer and Corporate Secretary | 12 Febbraio 2026 A | 28.125 | 0 | 0 | $0 |
| Andrew James King | Chief Scientific Officer & Head of Research and Development | 12 Febbraio 2026 A | 386.113 | 0 | 0 | $0 |
| Mark Eisner | Direttore | 25 Giugno 2026 A | — | 0 | 0 | $0 |
| Christopher W. Cain | Direttore | 09 Giugno 2026 A | — | 0 | 0 | $0 |
| Lawrence Otto Klein | Direttore | 09 Giugno 2026 A | — | 0 | 0 | $0 |
| Erin Lavelle | Direttore | 09 Giugno 2026 A | — | 0 | 0 | $0 |
| Eric Dobmeier | Direttore | 09 Giugno 2026 A | — | 0 | 0 | $0 |
| Allison Dorval | Direttore | 15 Luglio 2021 A | — | 0 | 0 | $0 |
| David S. Grayzel | Direttore | 02 Luglio 2021 C | 3.103.879 | 0 | 0 | $0 |
| Dr. Maha Katabi | Direttore | 02 Luglio 2021 C | 3.758.686 | 0 | 0 | $0 |
| Atlas Venture Fund XII, L.P. | Proprietario del 10% | 15 Luglio 2022 J | 2.327.909 | 0 | 0 | $0 |
| Benjamin T Dake | — | 29 Giugno 2021 A | — | 0 | 0 | $0 |
| Hunter Gillies | — | 29 Giugno 2021 A | — | 0 | 0 | $0 |
| Joshua Resnick | — | 29 Giugno 2021 A | — | 0 | 0 | $0 |
| Mark T Iwicki | — | 29 Giugno 2021 A | — | 0 | 0 | $0 |
| George A Eldridge | — | 29 Giugno 2021 A | — | 0 | 0 | $0 |
| Timothy P Noyes | — | 29 Giugno 2021 A | — | 0 | 0 | $0 |
| Ralph Niven | — | 29 Giugno 2021 A | — | 0 | 0 | $0 |
Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato
Attivisti e proprietari del 5%+ 5 partecipazioni
Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.
| Depositante | Depositato | Partecipazione | Stato | Scopo | Deposito |
|---|---|---|---|---|---|
| Fairmount Funds Management LLC, Fairmount Healthcare Fund II L.P., Fairmount Healthcare Co-Invest IV L.P., Peter Evan Harwin, Tomas Kiselak ×3 depositi | 09 Giugno 2026 | 19,99% | Modifica | — | SEC |
| Sofinnova Venture Partners X, L.P. ("SVP X"), Sofinnova Management X, L.P. ("SM X LP"), Sofinnova Management X-A, L.L.C. ("SM X LLC"), Dr. James I. Healy ("Healy"), Dr. Maha Katabi ("Katabi") | 05 Marzo 2026 | 0,30% | Modifica | Investimento passivo | SEC |
| Atlas Venture Fund XII, L.P., Atlas Venture Associates XII, L.P., Atlas Venture Associates XII, LLC ×5 depositi | 30 Aprile 2025 | 0,20% | Modifica | — | SEC |
| RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, RA Capital Healthcare Fund, L.P. ×5 depositi | 30 Aprile 2025 | 4,10% | Modifica | — | SEC |
| Sofinnova Venture Partners X, L.P. (“SVP X”), Sofinnova Management X, L.P. (“SM X LP”), Sofinnova Management X-A, L.L.C. (“SM X LLC”), Dr. James I. Healy (“Healy”), Dr. Maha Katabi (“Katabi”) ×3 depositi | 20 Febbraio 2024 | — | Deposito iniziale | Investimento passivo | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Proprietà ETF Posseduti da 24 ETF
Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.
| Fondo | Peso | Unità | Aggiornato al | Fonte |
|---|---|---|---|---|
| BBC · ETFis Series Trust I | 1,20% | 18.425 NS | 30 Aprile 2026 | N-PORT |
| FFSM · FIDELITY COVINGTON TRUST | 0,17% | 90.180 NS | 30 Aprile 2026 | N-PORT |
| IWC · iShares Trust | 0,16% | 110.226 SH | 08 Agosto 2026 | Giornaliero |
| VFMO · VANGUARD WELLINGTON FUND | 0,12% | 111.509 SH | 08 Agosto 2026 | Giornaliero |
| IWO · iShares Trust | 0,04% | 291.651 SH | 08 Agosto 2026 | Giornaliero |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,04% | 53.058 NS | 31 Maggio 2026 | N-PORT |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,04% | 34.886 SH | 08 Agosto 2026 | Giornaliero |
| IWM · iShares Trust | 0,02% | 834.822 SH | 08 Agosto 2026 | Giornaliero |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,02% | 187.416 SH | 08 Agosto 2026 | Giornaliero |
| ISCB · iShares Trust | 0,02% | 2.353 SH | 08 Agosto 2026 | Giornaliero |
| ITWO · ProShares Trust | 0,02% | 1.500 NS | 31 Maggio 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 489.225 SH | 08 Agosto 2026 | Giornaliero |
| VHT · VANGUARD WORLD FUND | 0,01% | 124.984 SH | 08 Agosto 2026 | Giornaliero |
| UWM · ProShares Trust | 0,01% | 1.173 NS | 31 Maggio 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,01% | 3.435 NS | 31 Maggio 2026 | N-PORT |
| WSML · iShares Trust | 0,01% | 2.542 SH | 08 Agosto 2026 | Giornaliero |
| URTY · ProShares Trust | 0,01% | 1.189 NS | 31 Maggio 2026 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0,01% | 25.716 NS | 31 Maggio 2026 | N-PORT |
| HDG · ProShares Trust | 0,00% | 30 NS | 31 Maggio 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 71.137 SH | 08 Agosto 2026 | Giornaliero |
| IWV · iShares Trust | 0,00% | 14.895 SH | 08 Agosto 2026 | Giornaliero |
| AVUS · AMERICAN CENTURY ETF TRUST | 0,00% | 5.087 NS | 31 Maggio 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1.699.343 SH | 08 Agosto 2026 | Giornaliero |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 2.733 SH | 08 Agosto 2026 | Giornaliero |